FDA
approval
· 2023-12-07
FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Apotex Corp.)
Summary
FDA approved Apotex Corp.'s original ANDA for eslicarbazepine acetate, a generic anticonvulsant, for use as adjunctive therapy in adults with partial-onset seiz…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)